4.5 Article

Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients: A population-based cohort study

Shau-Huai Fu et al.

Summary: Discontinuation of denosumab resulted in an increased risk of major osteoporotic fractures, especially vertebral fractures. The increased risk tends to reveal within 1 year post-discontinuation and be greater after a longer treatment duration.

JOURNAL OF INTERNAL MEDICINE (2021)

Editorial Material Oncology

Real-World Evidence in Oncology: Opportunities and Limitations

Massimo Di Maio et al.

ONCOLOGIST (2020)

Review Endocrinology & Metabolism

Persistence and adherence to parenteral osteoporosis therapies: a systematic review

G. Koller et al.

OSTEOPOROSIS INTERNATIONAL (2020)

Review Endocrinology & Metabolism

The epidemiology of osteoporosis, associated fragility fractures, and management gap in China

Fan Yu et al.

ARCHIVES OF OSTEOPOROSIS (2019)

Review Public, Environmental & Occupational Health

Taiwan's National Health Insurance Research Database: past and future

Cheng-Yang Hsieh et al.

CLINICAL EPIDEMIOLOGY (2019)

Review Endocrinology & Metabolism

Pragmatic Clinical Trials in Osteoporosis

Giovanni Adami et al.

CURRENT OSTEOPOROSIS REPORTS (2019)

Article Public, Environmental & Occupational Health

The Chang Gung Research Database-A multi-institutional electronic medical records database for real-world epidemiological studies in Taiwan

Shih-Chieh Shao et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2019)

Article Public, Environmental & Occupational Health

Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0

Shirley V. Wang et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)

Article Public, Environmental & Occupational Health

Validity of major osteoporotic fracture diagnosis codes in the Clinical Data Analysis and Reporting System in Hong Kong

Chor-Wing Sing et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)

Editorial Material Medicine, General & Internal

Real-World Evidence - What Is It and What Can It Tell Us?

Rachel E. Sherman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Multidisciplinary Sciences

Recent Clinical Trials in Osteoporosis: A Firm Foundation or Falling Short?

Karen Barnard et al.

PLOS ONE (2016)

Article Rheumatology

Active-comparator design and new-user design in observational studies

Kazuki Yoshida et al.

NATURE REVIEWS RHEUMATOLOGY (2015)

Article Endocrinology & Metabolism

Risk of refracture associated with compliance and persistence with bisphosphonate therapy in Taiwan

Y. -K. Soong et al.

OSTEOPOROSIS INTERNATIONAL (2013)

Article Endocrinology & Metabolism

Osteoporosis in the European Union: medical management, epidemiology and economic burden

E. Hernlund et al.

ARCHIVES OF OSTEOPOROSIS (2013)

Article Pharmacology & Pharmacy

Alendronate Adherence and Its Impact on Hip-Fracture Risk in Patients With Established Osteoporosis in Taiwan

T-C Lin et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)

Article Public, Environmental & Occupational Health

High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data

Sebastian Schneeweiss et al.

EPIDEMIOLOGY (2009)

Article Medicine, General & Internal

Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women

Dana Bliuc et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)

Article Endocrinology & Metabolism

An estimate of the worldwide prevalence and disability associated with osteoporotic fractures

O. Johnell et al.

OSTEOPOROSIS INTERNATIONAL (2006)

Article Public, Environmental & Occupational Health

Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics

Sebastian Schneeweiss

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2006)

Article Endocrinology & Metabolism

A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women

PJ Bekker et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2004)